HJLI
Hancock Jaffe Laboratories
Set alert
10.38 0.00 0.00%
10.26 Day range 10.74
52-week range unavailable
- Open
- 10.71
- Prev close
- 10.38
- Mkt cap
- 98.26M
- Vol
- 221.87K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.26
- High
- 10.74
- Forward P/E
- -9.98
- Beta
- 1.54
- Short ratio
- 2.54
- Inst. own
- 23.17%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2021
- 50-d avg
- 9.02
- 200-d avg
- 6.95
- 1y target
- 26.00
Financial health
Altman Z-Score
12.54 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.3×
FY 2015 5y median -1.1× FY 2025
P/S 0.0×
FY 2015 5y median 74.0× FY 2025
P/B 0.2×
FY 2015 5y median 4.2× FY 2025
P/FCF -0.4×
FY 2015 5y median -1.4× FY 2025
EV/EBITDA 7.7×
FY 2015 5y median 7.7× FY 2025
EV/Sales 0.0×
FY 2015 5y median 59.3× FY 2025
FCF Yield -254.7%
FY 2015 5y median -72.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2015 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2015 5y median -214.8% FY 2025
Net Margin 0.0%
FY 2015 5y median -214.8% FY 2025
ROE -71.8%
FY 2015 5y median -71.8% FY 2025
ROIC -75.1%
FY 2015 5y median -75.1% FY 2025
ROA -65.9%
FY 2015 5y median -91.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2015 FY 2025
Operating Income 12.3%
FY 2015 FY 2025
EPS (diluted) -2503.1%
FY 2015 FY 2025
Free Cash Flow 7.7%
FY 2015 FY 2025
Financial Health
Current Ratio 13.6×
FY 2015 5y median 3.0× FY 2025
Quick Ratio 13.6×
FY 2015 5y median 3.0× FY 2025
Debt / Equity 0.0×
FY 2015 5y median 0.0× FY 2025
Net Debt / EBITDA -4.8×
FY 2015 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2015 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31